Show Notes
Prof. Anette-Gabriele Ziegler, this year’s Claude Bernard Prize Lecture recipient, reflects on her career in type 1 diabetes research and the evolution of our understanding of the disease.
From the early recognition of type 1 diabetes as an autoimmune disease to pioneering birth cohort studies, early detection and screening, Prof. Ziegler discusses the discoveries that have shaped the field and the emergence of treatments that can delay disease progression.
She also discusses what remains to be understood about disease progression, possible environmental modifiers and the future of type 1 diabetes prevention.
More from Diabetes Insights - Breakthroughs and Innovators
In this EASD TV interview, Prof. Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research), 61st EASD Minkowski Prize recipient, discusses research into the neurokinin-2 receptor (NK2R) and its potential to change how we approach weight management and metabolic health. Where many existing treatments focus on reducing food intake, NK2R activation could offer a complementary strategy by increasing energy expenditure, influencing appetite and improving insulin sensitivity.
How does exercise stimulate glucose uptake in muscle and what can this teach us about treating type 2 diabetes?
The EASD’s first clinical practice guideline on the assessment and management of diabetes distress in adults living with type 1 or type 2 diabetes has now been published in Diabetologia.
How can people living with diabetes help shape the future of diabetes care?
In this episode, Dr Jeroen van der Velde explores one of the most common questions in lifestyle medicine: does the time of day you exercise make a difference?